Accelerating drug development with an AI-enabled full body molecular scan of inflammation
Romix Biosciences has raised $600K in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2025.
Romix Biosciences's investors include 2048 Ventures, ARC Capital Management.
Romix Biosciences is headquartered in New York, United States.
Accelerating drug development with an AI-enabled full body molecular scan of inflammation
Romix Biosciences is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Romix Biosciences — Funding & Investors." VCBacked, July 30, 2025, https://www.vcbacked.co/company/romix-biosciences. Accessed September 30, 2026.
VCBacked. (2025). Romix Biosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/romix-biosciences
{{cite web |title=Romix Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/romix-biosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated